XoMotion-R Exoskeleton for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called the XoMotion-R, a self-balancing exoskeleton that helps people with spinal cord injuries walk without using their hands. The research targets individuals who can move their legs but struggle with weak upper body strength, preventing the use of walkers or crutches. Participants will use the exoskeleton during rehab to determine if it improves walking and overall recovery. The study seeks individuals hospitalized or undergoing outpatient rehab who wish to enhance their walking ability. As an unphased trial, this study offers a unique opportunity to explore innovative rehabilitation technology and potentially enhance the recovery journey.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the XoMotion-R exoskeleton is safe for spinal cord injury patients?
Research has shown that the XoMotion-R exoskeleton is generally safe for people with spinal cord injuries (SCI). Studies have used exoskeletons for walking training without major safety issues. Research on similar devices indicates they are well-tolerated and can improve walking ability. Most users do not experience serious side effects, though some may feel mild discomfort as they adjust to the device.
One study highlighted that exoskeletons can encourage neuroplasticity, the brain's ability to adapt and change, and help reduce complications from SCI. These findings suggest that using an exoskeleton like the XoMotion-R can be a safe part of rehabilitation. While each person may respond differently, current evidence supports the safety of this technology for those looking to regain mobility after a spinal cord injury.12345Why are researchers excited about this trial?
Researchers are excited about the XoMotion-R Exoskeleton because it offers a unique approach to spinal cord injury rehabilitation. Unlike traditional therapies that often rely on passive exercises or manual assistance, the XoMotion-R actively engages patients in walking with a self-balancing exoskeleton, promoting early weight-bearing and postural control. This exoskeleton allows for individualized training that adapts to a patient's progress, potentially accelerating recovery and improving independence. Additionally, the focus on functional activities like sit-to-stand transitions and obstacle negotiation could enhance daily living skills and quality of life in ways that standard therapies might not.
What evidence suggests that the XoMotion-R exoskeleton is effective for spinal cord injury?
Research has shown that training with exoskeletons can greatly improve walking independence for people with incomplete spinal cord injuries. In this trial, participants will join either an inpatient or outpatient group, both using the XoMotion-R exoskeleton. Studies have found that robotic therapy, like the XoMotion-R, enhances walking ability and quality of life more than standard treatments alone. In one study, participants randomly assigned to different groups showed better lower body movement when using exoskeletons. Other research also supports that these devices can help improve walking over time. Overall, the evidence suggests that exoskeletons are a promising tool for enhancing mobility in people with spinal cord injuries.14678
Who Is on the Research Team?
Jessica M D'Amico, PhD
Principal Investigator
University of Alberta and Alberta Health Services
Are You a Good Fit for This Trial?
This trial is for individuals with a Spinal Cord Injury (SCI) who have an American Spinal Injury Association Impairment Scale rating of B-D. It's aimed at those wanting to improve walking abilities and are either inpatient or outpatient participants willing to use the XoMotion-R exoskeleton during rehabilitation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Inpatient Treatment
Inpatient participants receive locomotor therapy with the XoMotion-R for 30-45 minutes, 2-3 times per week, focusing on early weight-bearing and postural control
Outpatient Treatment
Outpatient participants receive locomotor therapy with the XoMotion-R for 30-45 minutes, 2-3 times per week, focusing on increased walking distance and community-based ambulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- XoMotionR
Trial Overview
The study tests the XoMotion-R, a self-balancing exoskeleton designed for hands-free walking by people with certain levels of SCI. The goal is to see if it can help improve their ability to walk and reduce hospital stay, complications, and long-term disability.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Through our Specialized Outpatient Rehabilitation Program or Research Lab in the Courage Centre, SCI outpatients will be recruited and the XoMotionR will be incorporated into their locomotor therapy program for approximately 30-45minutes, 2-3 times per week, up to 6 weeks. Outpatient intervention will follow a task-specific approach emphasizing increased walking distance, reduced exoskeleton assistance, and advancement toward community-based ambulation goals. In this phase, the focus shifts toward higher-level gait tasks, including multi-surface walking, obstacle negotiation, and endurance training. Individuals are encouraged to use assistive devices with progressively less support as their neuromuscular control improves.
During their inpatient rehabilitation, the XoMotionR will be incorporated into their locomotor therapy program for approximately 30-45minutes, 2-3 times per week, up to 6 weeks. Inpatient intervention will be focused on promoting early weight-bearing, postural control, and initiation of step cycles. Training includes progressive walking tasks that emphasize symmetrical lower limb loading, upright posture, and engagement of trunk musculature. In addition to forward ambulation, sessions incorporate functional activities such as sit-to-stand transitions, pivot turns, and standing balance tasks which are all possible with the self-balancing XoMotion-R. The intervention is individualized based on tolerance, cardiovascular response, and patient progress, with adjustments made to walking speed, step length, and assistance levels over time.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Praxis Spinal Cord Institute
Collaborator
Citations
Xo-Motion R Exoskeleton in SCI-Adoption Study
This study seeks to determine the safety and feasibility of the XoMotion-R, a self-balancing exoskeleton that allows people with American Spinal ...
Effects of an exoskeleton robot on motor function in patients ...
Exoskeleton-based training improves walking independence in incomplete spinal cord injury patients: results from a randomized controlled trial.
The use of exoskeleton robotic training on lower extremity ...
Robotic Therapy could improve ambulation/quality of life in patients with spinal cord injuries compared to the standard treatment only.
Exoskeleton home and community use in people with ...
Walking improvement in chronic incomplete spinal cord injury with exoskeleton robotic training (WISE): a randomized controlled trial.
Comparative efficacy of robotic exoskeleton and conventional ...
This meta-analysis aims to explore the effectiveness of lower limb robotic exoskeletons in rehabilitation training for patients with SCI. Our ...
Exoskeletons for Mobility after Spinal Cord Injury - PMC - NIH
Gait training after spinal cord injury: Safety, feasibility and gait function following 8 weeks of training with the exoskeletons from Ekso ...
Exoskeleton-Assisted Rehabilitation and Neuroplasticity in ...
Exoskeleton serves as an emerging and promising tool for rehabilitation, especially in promoting neuroplasticity and alleviating SCI-related complications.
Frontiers | Safety and Feasibility of a Novel Exoskeleton for ...
The advent of exoskeletal robotic technology can benefit the spinal cord injury population in three ways: (1) extensive repetitions of walking ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.